ISSN: 1859 - 2872
Evaluating of treatment outcomes in patients with middle cerebral artery occlusion-induced ischemic stroke indicated for decompressive craniectomy at 108 Military Central Hospital
Main Article Content
Keywords
Abstract
To evaluate the treatment outcomes of patients with ischemic stroke due to middle cerebral artery (MCA) occlusion who were indicated for decompressive craniectomy at the 108 Military Central Hospital. Subject and method: A retrospective descriptive study was conducted from January 2022 to December 2024 on 53 patients with ischemic stroke due to MCA occlusion who had indications for decompressive craniectomy at the 108 Military Central Hospital. Treatment outcomes were assessed. Result: At discharge, the mortality rate in the surgical group was 16.1%, compared to 27.3% in the non-surgical group. At 6 months post-discharge, in the surgical group, favorable outcomes were observed in 35.5% of patients, unfavorable outcomes in 35.5%, and mortality in 29.0%. In contrast, the mortality rate in the non-surgical group was 89.9%, compared to 29.0% in the surgical group. Conclusion: Based on observational research, it was found that: At 6 months, favorable outcomes were observed in 35.5% of patients with large middle cerebral artery infarction who underwent decompressive craniectomy, with a mortality rate of 29.0%. In contrast, no favorable outcomes (mRS 0-3) were observed in the non-surgical group, which had a mortality rate of 89.9%.
Article Details
References
2. Powers WJ, Derdeyn CP, Biller J et al (2015) 2015 AHA/ASA focused update of the 2013 guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment, A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke 46(10): 3020-3035.
3. Hofmeijer J, Kappelle LJ, Algra A et al (2009) Surgical decompression for space-occupying cerebral infarction (the Hemicraniectomy After Middle Cerebral Artery infarction with Life-threatening Edema Trial [HAMLET]): a multicentre, open, randomised trial. Lancet Neurol 8(4): 326-333.
4. Vahedi K, Hofmeijer J, Juettler E et al (2007) Early decompressive surgery in malignant infarction of the middle cerebral artery: A pooled analysis of three randomised controlled trials. Lancet Neurol 6(3): 215-222.
5. Jüttler E, Schwab S, Schmiedek P et al (2007) Decompressive Surgery for the Treatment of Malignant Infarction of the Middle Cerebral Artery (DESTINY): A randomized, controlled trial. Stroke. 38(9): 2518-2525.
6. Jüttler E, Schellinger PD, Aschoff A et al (2007) Clinical review: Therapy for refractory intracranial hypertension in ischaemic stroke. Crit Care11(5): 231.
7. Alexander Paul, Heels-Ansdell Diane, Siemieniuk Reed et al (2016) Hemicraniectomy versus medical treatment with large MCA infarct: A review and meta-analysis. BMJ Open 6: 014390.
8. Heiss WD (2016) Malignant MCA Infarction: Pathophysiology and Imaging for Early Diagnosis and Management Decisions. Cerebrovasc Dis 41(1-2): 1-7.
9. Berrouschot J, Sterker M, Bettin S et al (1998) Mortality of space-occupying ('malignant') middle cerebral artery infarction under conservative intensive care. Intensive Care Med. 24(6): 620-623.
10. Hacke W, Schwab S, Horn M et al (1996) 'Malignant' middle cerebral artery territory infarction: clinical course and prognostic signs. Arch Neurol 53(4): 309-315.
11. Pilato F, Pellegrino G, Calandrelli R et al (2022) Decompressive hemicraniectomy in patients with malignant middle cerebral artery infarction: A real-world study. J Neurol Sci 441: 120376.
Article Sidebar
